Indiana officials are right to scrutinize how taxpayer dollars are spent, but when it comes to the proposed elimination of the federal 340B drug discount program, the state needs to be cautious. The ...

AbbVie is spearheading a new battle in pharma’s long-running fight to reform the federal government’s 340B drug discount ...

A federal prescription drug discount program meant to support underserved patients has been leveraged by large hospitals to ...

April 8 (Reuters) - AbbVie has filed a lawsuit against the U.S. government, seeking clearer guidance on patients eligible for ...

Pharmaceutical companies are spending hundreds of millions lobbying elected officials to try and persuade them to gut the ...

Drug companies want to end it. This is not a partisan issue. It is a math issue. And for the patients and communities we serve, it is a survival issue.

Tuesday’s bill gives powers to the Attorney General’s Office to further enforce state law that prohibits manufacturers from ...

AbbVie sues HHS over 340B patient definition to tighten eligibility and prevent duplicate discounts in federal drug pricing ...

Both drugmakers filed complaints in the U.S. District Court for the Western District of Washington and asked judges for an ...

On April 28, AEI’s Kirsten Axelsen hosted the former North Carolina Department of Health and Human Services Secretary Kody Kinsley; Anthony DiGiorgio of the University of California, San Francisco; ...

Catholic healthcare was not started nor inspired from profit and loss statements or a desire to drive more shareholder value. Instead, through acts of mercy, women religious crossed oceans on ...

Ravin Consultants announced today a leadership evolution that reflects the strength of its foundation and its long-term vision for the future of the 340B program. This press release features ...